Ammonia n-13
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
101 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Inborn urea cycle disorders | D056806 | — | E72.2 | 1 | 3 | — | 2 | 6 | 11 |
| Coronary artery disease | D003324 | — | I25.1 | 1 | 1 | — | 1 | 5 | 8 |
| Heart diseases | D006331 | EFO_0003777 | I51.9 | 1 | — | — | 1 | 2 | 4 |
| Dental caries | D003731 | EFO_0003819 | K02 | — | — | — | 1 | 3 | 4 |
| Pulmonary hypertension | D006976 | EFO_0001361 | I27.20 | — | 1 | — | 1 | 1 | 3 |
| Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | — | 1 | 1 | 2 |
| Heart failure | D006333 | EFO_0003144 | I50 | — | — | — | 1 | — | 1 |
| Pulmonary arterial hypertension | D000081029 | — | — | — | — | — | 1 | — | 1 |
| Familial primary pulmonary hypertension | D065627 | — | I27.0 | — | — | — | 1 | — | 1 |
| Prostatic neoplasms | D011471 | — | C61 | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Brain diseases | D001927 | — | G93.40 | — | 3 | 1 | — | 10 | 14 |
| Hepatic encephalopathy | D006501 | — | K72.91 | — | 3 | 1 | — | 10 | 14 |
| Fibrosis | D005355 | — | — | — | 3 | 1 | — | 9 | 12 |
| Hyperammonemia | D022124 | — | E72.20 | — | 2 | 1 | — | — | 2 |
| Portal hypertension | D006975 | EFO_0000666 | K76.6 | — | 1 | 1 | — | 1 | 2 |
| Hyperargininemia | D020162 | Orphanet_90 | E72.21 | — | — | 2 | — | — | 2 |
| Ascites | D001201 | — | R18 | — | 1 | 1 | — | 1 | 2 |
| Breast neoplasms | D001943 | EFO_0003869 | C50 | — | — | 1 | — | — | 1 |
| Inborn errors metabolism | D008661 | — | — | — | 1 | 1 | — | — | 1 |
| Heart arrest | D006323 | EFO_0009492 | I46 | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Liver cirrhosis | D008103 | EFO_0001422 | K74.0 | — | 1 | — | — | 13 | 14 |
| Liver failure | D017093 | — | K72.9 | — | 2 | — | — | 8 | 10 |
| Hepatic insufficiency | D048550 | — | — | — | 1 | — | — | 7 | 8 |
| Acute-on-chronic liver failure | D065290 | — | — | — | 1 | — | — | 6 | 7 |
| Acute liver failure | D017114 | — | — | — | 2 | — | — | 4 | 6 |
| Liver diseases | D008107 | EFO_0001421 | K70-K77 | — | 1 | — | — | 3 | 4 |
| Ornithine carbamoyltransferase deficiency disease | D020163 | EFO_0007409 | E72.4 | 1 | 1 | — | — | 3 | 4 |
| Hypertension | D006973 | EFO_0000537 | I10 | — | 1 | — | — | 2 | 3 |
| Hepatitis | D006505 | — | K75.9 | — | 1 | — | — | 2 | 3 |
| Phenylketonurias | D010661 | — | E70.0 | — | 2 | — | — | — | 2 |
Show 9 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cardiomyopathies | D009202 | EFO_0000318 | I42 | 1 | — | — | — | 2 | 3 |
| Coronary disease | D003327 | — | — | 1 | — | — | — | 1 | 2 |
| Recurrence | D012008 | — | — | 1 | — | — | — | — | 1 |
| Carcinoma | D002277 | — | C80.0 | 1 | — | — | — | — | 1 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | — | — | — | — | 1 |
| Ovarian epithelial carcinoma | D000077216 | — | — | 1 | — | — | — | — | 1 |
| Sleep deprivation | D012892 | — | F51.12 | 1 | — | — | — | — | 1 |
| Stress fractures | D015775 | — | M84.3 | 1 | — | — | — | — | 1 |
| Sleep | D012890 | GO_0030431 | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| End stage liver disease | D058625 | EFO_1001311 | K72.1 | — | — | — | — | 6 | 6 |
| Metabolic diseases | D008659 | EFO_0000589 | E88.9 | — | — | — | — | 4 | 4 |
| Parkinson disease | D010300 | EFO_0002508 | G20 | — | — | — | — | 2 | 2 |
| Pure autonomic failure | D054970 | — | — | — | — | — | — | 2 | 2 |
| Myocardial infarction | D009203 | EFO_0000612 | I21 | — | — | — | — | 2 | 2 |
| Infarction | D007238 | EFO_0009463 | — | — | — | — | — | 2 | 2 |
| Multiple system atrophy | D019578 | — | — | — | — | — | — | 1 | 1 |
| Autonomic nervous system diseases | D001342 | EFO_0009532 | G90 | — | — | — | — | 1 | 1 |
| Propionic acidemia | D056693 | — | E71.121 | — | — | — | — | 1 | 1 |
| Immunoglobulin light-chain amyloidosis | D000075363 | — | — | — | — | — | — | 1 | 1 |
Show 35 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | — |
| INN | — |
| Description | — |
| Classification | Unknown |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | — |
Identifiers
| PDB | — |
| CAS-ID | — |
| RxCUI | — |
| ChEMBL ID | — |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 107,028 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
74 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use